Bristol Myers's most recent trend suggests a bullish bias. One trading opportunity on Bristol Myers is a Bull Put Spread using a strike $52.50 short put and a strike $47.00 long put offers a potential 19.05% return on risk over the next 26 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $52.50 by expiration. The full premium credit of $0.88 would be kept by the premium seller. The risk of $4.62 would be incurred if the stock dropped below the $47.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Bristol Myers is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Bristol Myers is bullish.
The RSI indicator is at 71.35 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Bristol Myers
Don't Buy Ariad Pharmaceuticals Shares At These Levels
Mon, 23 Dec 2013 13:30:08 GMT
Seeking Alpha – Ariad Pharmaceuticals Inc. ( ARIA ) delivered an early Christmas gift to investors on Friday morning, when the company announced that the FDA had approved revised U.S. Prescribing Information (USPI) and …
Bristol-Myers sale of diabetes franchise positive, says BMO Capital
Mon, 23 Dec 2013 12:52:11 GMT
theflyonthewall.com – Bristol-Myers sale of diabetes franchise positive, says BMO Capital
Bristol-Myers – Good News And Diabetes Sale Push Shares Higher
Mon, 23 Dec 2013 06:05:08 GMT
Seeking Alpha – Investors in Bristol-Myers Squibb ( BMY ) react favorably to the announced sale of its diabetes activities towards AstraZeneca ( AZN ), allowing the company to fully focus on cancer research and biotechnology. …
Bristol Myers Squibb and AstraZeneca: A Big Break-Up in the Diabetes Space
Sat, 21 Dec 2013 14:32:07 GMT
Motley Fool – A large deal could send ripples through the diabetes space.
In a true bull market: Cramer
Fri, 20 Dec 2013 23:00:00 GMT
CNBC – Mad Money host Jim Cramer shares the 5 tenets that prove we are in a true bull market.
Also on Market Tamer…
Follow Us on Facebook